Abstract 60P
Background
A group of spindle cell tumors with characteristic morphologic features and recurrent gene rearrangements has recently been described. Genome-wide DNA methylation profiling has emerged as a powerful tool for both robust classification of known sarcoma entities and identification of novel and clinically relevant subclasses of soft tissue tumors with characteristic alterations.
Methods
Anchored Multiplex polymerase chain reaction amplicons were sequenced on Illumina MiSeq and the data were analyzed using the Archer and Arriba software. Genome-wide DNA methylation profiling was performed using Infinium Methylation EPIC (EPIC) BeadChip (Illumina).
Results
We identified 6 spindle cell sarcoma cases with rearrangement/SNV in BRAF gene, 3 pediatric spindle cell sarcomas with NTRK1 fusion, 1 high-grade sarcoma with ALK fusion and 1 pediatric sarcoma with tyrosine-kinase duplication of EGFR gene. We show that CDKN2A deletion was the most prevalent DNA copy number aberration in spindle cell sarcomas for which this deletion is a typical change and connecting element across different subgroups of spindle cell sarcomas and this change was associated with poor clinical outcome. DNA methylation profiling demonstrated that 5 of our BRAF altered spindle cell sarcomas clustered within MPNST-like methylation class, but methylation analysis classified the next BRAF rearranged case (with CUX1::BRAF fusion) near to angiomatoid fibrous histiocytomas or inflammatory myofibroblastic tumors. Our patients with LMNA::NTRK1 fusion gene clustered within dermatofibrosarcoma protuberans methylation class. Methylation analysis of the sample with ALK fusion did not classify the sample in any of the defined class of methylation classifier.
Conclusions
The current study demonstrates, that all detected rearrangements in our spindle cell cohort are potentially therapeutically targetable. We provide evidence for the pathobiological and epigenetical heterogeneity of spindle cell sarcomas generally, and also of spindle cell sarcomas that shows alteration of the tyrosin-kinase genes.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Ministry of Health, Czech Republic - Conceptual Development of Research Organization, Motol University Hospital, Prague, Czech Republic 00064203.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
20P - Effects of <italic>Apis dorsata</italic> honey on the expression of selected CYP450, pro-apoptotic, and anti-apoptotic genes during induced cytotoxicity in cyclophosphamide-treated human lung carcinoma (A549) cells
Presenter: Jose Kenneth Narag
Session: Cocktail & Poster Display session
Resources:
Abstract
21P - Hsa_circ_0009061 inhibits the progression of bladder cancer through the miR-889-3p/CPEB3 axis
Presenter: Minkang Wu
Session: Cocktail & Poster Display session
Resources:
Abstract
22P - Exploring exportin-1 as a therapeutic vulnerability in lung squamous cell carcinoma
Presenter: Vidushi Durani
Session: Cocktail & Poster Display session
Resources:
Abstract
23P - Identification of HPSE as potential novel therapeutic target for lung adenocarcinoma patients
Presenter: Samuel Doré
Session: Cocktail & Poster Display session
Resources:
Abstract
24P - High-throughput plasma proteomics profiling in early breast cancer
Presenter: Isabella Lombardo
Session: Cocktail & Poster Display session
Resources:
Abstract
25P - Immunohistochemical analysis of ROR1 and BMI-1 expression in luminal breast cancer
Presenter: Sergey Vtorushin
Session: Cocktail & Poster Display session
Resources:
Abstract
26P - Associations between cancer stem cells (CSC) markers and androgen (AR) and estrogen (ER) receptors expression in prostate cancer (PCa)
Presenter: Marina Puchinskaya
Session: Cocktail & Poster Display session
Resources:
Abstract
27P - Proteomic profiling reveals organ-specific differences in metastases and identifies potential biomarkers for recurrence risk in localized colon cancer
Presenter: Blanca García-Micó
Session: Cocktail & Poster Display session
Resources:
Abstract
28P - Collagen-activated signalling pathway is significantly hypermethylated in high-grade serous ovarian cancer (HGSOC) patients treated with platinum-containing neoadjuvant chemotherapy (NACT)
Presenter: Jose Alejandro Perez Fidalgo
Session: Cocktail & Poster Display session
Resources:
Abstract
29P - Quantitative tissue analysis reveal adenylate kinase 2 protein signatures: Therapeutic target for meningioma
Presenter: Rashmi Rana
Session: Cocktail & Poster Display session
Resources:
Abstract